Automated Immunoassay Analyzers Market worth over $25bn by 2024
Date: 2018-09-10   Author: Rahul Sankrityayan  Category: #industry

Global Automated Immunoassay Analyzers Market size is set to exceed USD 25 billion by 2024; according to a new research study published by Global Market Insights, Inc.

Market Overview and Growth Factors:

Rising prevalence of infectious diseases and growing geriatric population has led to high diagnostic test volumes, aiding a trend shift towards lab automation. Technological innovation for development of effective lab equipment will drive global automated immunoassay analyzers market.

Increasing consolidation in laboratories and hospitals in the wake of health care reform to curb healthcare expenses should stimulate the industry growth. Rising number of centralized laboratories and large reference labs should escalate the demand for automated immunoassay analyzer systems.

Adoption of innovative diagnostic technologies should lead to prolific growth in automated immunoassay analyzers market. New product launches with ability to perform more than one test at a time using software allows diagnostic laboratories to perform routine as well as specialized tests.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1727

Prominent Players:

Some of the prominent industry players in the competitive market include Abbott Diagnostics, Biokit, Carolina Liquid Chemistries Corporation, Luminex Corporation, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare.

The automated immunoassay analyzers market is dominated by few companies with a strong financial muscle, expanded geographical footprint, and extensive product portfolio. New product launch or customizing existing product by adding broad assay of test menus is the major trend adopted by industry participants to hold their market position.

Regional Analysis:

Infectious diseases should witness a healthy growth to surpass USD 7 billion by 2024. Rising incidence of infectious diseases, growing elderly population and improved healthcare systems is set to drive segment growth.

U.S. automated immunoassay analyzers market accounted for more than 90% of regional industry revenue in 2016. Favorable healthcare reforms for diagnostic care, adoption of innovative products and increasing consolidation of laboratories should boost demand for automated instruments used for high volume testing.

India should witness robust regional growth over forecast years owing to increasing government focus towards development of healthcare infrastructure by encouraging public private partnership to improve healthcare delivery into rural markets. Furthermore, increasing number of pathology laboratories and rising number of private and public hospitals should fuel automated immunoassay analyzers market growth.



About Author


Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for AlgosOnline, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in t...

Read More

More from Rahul


Post Recommendents

Pancreatic Cancer Treatment Market Set for Rapid Growth
Author: Rahul Sankrityayan

Global Pancreatic Cancer Treatment Market size is projected to experience significant growth from 2017 to 2024. Pancreatic cancer treatment market size should witness significant growth due to increasing healthcare exp...


Angiography Devices Market In-Depth Progress Research 2017-2024
Author: Rahul Sankrityayan

Global Angiography Devices Market size is projected to experience significant growth from 2017 to 2024. Growing incidence of cardiac disorders such as coronary artery, congenital, pericardial, heart valve and aorta dis...


Scaffold Technology Market Outlook, Research, Trends and Forecast to 2024
Author: Rahul Sankrityayan

Global Scaffold Technology Market size is projected to experience significant growth from 2017 to 2024.

The increasing R&D investment, growing need for organ transplantation, ad...